Federico Damilano is a highly experienced biomedical researcher specializing in metabolism and cardiac physiology. Currently serving as a Senior Principal Scientist at Pfizer, Federico has previously held roles at Massachusetts General Hospital as an Instructor of Medicine and Research Fellow, focusing on molecular alterations in familial dilated cardiomyopathy and providing mentorship in advanced research techniques. Federico's career also includes a Principal Scientist position at Pfizer, postdoctoral research at Beth Israel Deaconess Medical Center, and contributions to developing an echocardiography core at the Università degli Studi di Torino. Federico holds a PhD in Molecular Cardiology and an MS in Molecular Biotechnology, both from Università degli Studi di Torino.
This person is not in the org chart
This person is not in any teams
This person is not in any offices